Author Topic: Credit Operation Warp Speed in part for Novavax's stunning vaccine success  (Read 196 times)

0 Members and 1 Guest are viewing this topic.

Offline PeteS in CA

  • Hero Member
  • *****
  • Posts: 19,026
Credit Operation Warp Speed in part for Novavax's stunning vaccine success

https://hotair.com/allahpundit/2021/06/14/credit-operation-warp-speed-in-part-for-novavaxs-stunning-vaccine-success-n396680

Quote
Jazz mentioned in his thread this morning about Novavax’s impressive trial results that it’s a product of Operation Warp Speed but that subject deserves more attention. Why? Because Novavax was a longshot when the feds threw $1.6 billion at it for its COVID vaccine last year. ...
...
Not only is Novavax a small company, it hadn’t successfully brought a vaccine to market in more than 30 years of trying when it won its contract with the feds under OWS. Its setbacks from having some of its other vaccine candidates go bust during trials led it to lay off a third of its staff at one point and nearly saw Nasdaq delist its stock. It even sold its manufacturing facilities to a competitor when it needed cash. That’s not an obvious racehorse for the federal government to bet big on. In fact, this NYT piece from last summer about Novavax’s huge contract — bigger even than the one given to AstraZeneca — strongly implied that the company may have drummed up interest from the feds via cronyism ... .
...
... but today’s data feels like vindication, making Warp Speed’s lavish support for Novavax look less like a corrupt bit of favoritism for tapped-in underachievers than a canny bet on an underdog with real potential. ... Their COVID vaccine process relies on moth cells to crank out copies of SARS-CoV-2’s spike protein, which are then adapted for incorporation into the vaccine. That process is fast, the Times noted in its piece last year, which is why the Trump administration and other governments mired in a raging pandemic took an interest in it.

If one steps back and looks at the companies Trump's OWS worked with for vaccines - AstraZeneca, Inovio, Johnson & Johnson, Moderna, Novavax, Pfizer, Sanofi, and Vaxart - one sees a couple of interesting patterns. Half of the companies are pharma-giants, and half are small struggling companies. Among them there are three different vaccine technologies - mRNA, viral vector, and protein subunit - each with different production bases and processes. On multiple levels, OWS avoided putting taxpayers' vaccine eggs into just one basket. A "side-effect" of the scale of OWS is that it shepherded vaccines into production not just sufficient for the US, but ultimately for much of the world.

Looking forward, Novavax will be submitting for FDA EUA in a few weeks, and looks likely to get it (probably after the FDA's seemingly ritual 3 week delay after official request). Farther out, Sanofi's vaccine is in Phase 3 testing, Inovio's vaccine is in Phase 3 testing, and Vaxart's oral vaccine is in Phase 2 testing.
If, as anti-Covid-vaxxers claim, https://www.poynter.org/fact-checking/2021/robert-f-kennedy-jr-said-the-covid-19-vaccine-is-the-deadliest-vaccine-ever-made-thats-not-true/ , https://gospelnewsnetwork.org/2021/11/23/covid-shots-are-the-deadliest-vaccines-in-medical-history/ , The Vaccine is deadly, where in the US have Pfizer and Moderna hidden the millions of bodies of those who died of "vaccine injury"? Is reality a Big Pharma Shill?

Millions now living should have died. Anti-Covid-Vaxxer ghouls hardest hit.